Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma

NCT03110562 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

402

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

DRUG: Selinexor
DRUG: Bortezomib
DRUG: Dexamethasone

Sponsor

Karyopharm Therapeutics Inc